4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-24-002989
President & CEO sold 30,000 shares at $45.00 ($1,350,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAKKIS EMIL D President & CEO | 2024-02-07 | Sale | −30,000 | $45.00 | $1,350,000 | 539,770 | D: show line 1 in the form |
| Open-market sales · 30,000 sh · avg $45.00 · $1,350,000 | |||||||
Loading xslF345X05/doc4.xml…